Shanghai Fudan-zhangjiang Bio-pharmaceutical . Stock Forecast

Sell candidate since Nov 17, 2025 Loss -4.88%

The Shanghai Fudan-Zhangjiang stock price fell by -4.88% on the last day (Tuesday, 18th Nov 2025) from HK$3.28 to HK$3.12. During the last trading day the stock fluctuated 6.43% from a day low at HK$3.11 to a day high of HK$3.31. The price has risen in 6 of the last 10 days but is still down by -4% for this period. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 4 million shares were bought and sold for approximately HK$13.11 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.32% during the next 3 months and, with a 90% probability hold a price between HK$2.49 and HK$3.01 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

1349.HK Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Shanghai Fudan-Zhangjiang stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at HK$3.26 and HK$3.36. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, September 16, 2025, and so far it has fallen -21.80%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Shanghai Fudan-Zhangjiang stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved HK$0.200 between high and low, or 6.43%. For the last week the stock has had daily average volatility of 3.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (1349.HK) For The Upcoming Trading Day Of Wednesday 19th

For the upcoming trading day on Wednesday, 19th we expect Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. to open at HK$3.18, and during the day (based on 14 day Average True Range), to move between HK$3.07 and HK$3.17, which gives a possible trading interval of +/-HK$0.108 (+/-3.52%) up or down from last closing price. If Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. takes out the full calculated possible swing range there will be an estimated 3.52% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ HK$3.57, some HK$0.450 (14.42%) from the current price of HK$3.12, our system finds the risk reward not very attractive.

Is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. stock A Buy?

Shanghai Fudan-Zhangjiang holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.520 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 19, 2025 - HK$3.18 ( 1.92%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk